← Leaderboards
Martha L Barnett
University Of Virginia Charlottesville
$513,002
Attributed
$513,002
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$513,002 · 2
By mechanism
M01$513,002 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia Charlottesville
Same institution · by research overlap
- Shu Man Fu$19,462,975
- Coleen A McNamara$22,811,214
- Wael N Jarjour$2,964,134
- Umesh S Deshmukh$7,411,901
- Mark Douglas Okusa$24,807,098
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectB LymphocyteConnective Tissue Disorder ChemotherapyDosageGenetic MarkersSystemic Lupus ErythematosusAntibody TiteringKidney Disorder ChemotherapyOligonucleotidesAntibody FormationHuman Therapy EvaluationBlood ChemistryRheumatoid ArthritisImmunologic Assay /Test
Grant awards (6)
DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF LJP 394 IN PATIENTS W/ SLE$48,533
M01 · FY2002 · RR
DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF LJP 394 IN PATIENTS W/ SLE$48,533
M01 · FY2001 · RR
IMMUNOLOGIC TESTING IN PATIENTS W/ RHEUMATOID ARTHRITIS$193,916
M01 · FY2000 · RR
IMMUNOLOGIC TESTING IN PATIENTS W/ RHEUMATOID ARTHRITIS$193,916
M01 · FY2000 · RR
DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF LJP 394 IN PATIENTS W/ SLE$28,104
M01 · FY2000 · RR
DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF LJP 394 IN PATIENTS W/ SLE$0
M01 · FY2000 · RR